Harrington Discovery Institute

Harrington Discovery Institute is a non-profit medical accelerator based at University Hospitals in Cleveland, Ohio. It focuses on advancing breakthrough discoveries by physician-scientists into novel treatments, addressing the 'valley of death' in drug development by providing funding and support to early-stage projects. The institute collaborates with academic medical centers, research institutions, and universities across the United States, United Kingdom, and Canada to identify and de-risk promising therapeutic candidates.

The institute's strategy includes offering grant funding, drug and business development support, and opportunities for acceleration and investment funds. Through partnerships with organizations like Advent Life Sciences, BioMotiv, and the Oxford-Harrington Rare Disease Centre, Harrington Discovery Institute aims to advance medicines for unmet needs, particularly in rare diseases. Its portfolio encompasses a wide range of therapeutic areas, including oncology, neurology, cardiology, and immunology.

Harrington Discovery Institute's philosophy centers on a collaborative, non-profit/for-profit model that integrates drug development expertise, financial resources, and industry collaborations. This approach has led to the advancement of numerous medicines into clinical trials and commercialization, demonstrating a commitment to translating innovative scientific discoveries into tangible health solutions for patients worldwide.